| 产品描述: | SIRT1 选择性抑制剂 | 活化剂 | 调节剂;SIRT1 Selective Inhibitors | Activators | Modulators;;InformationSRT2104 (GSK2245840) is a selectiveSIRT1activator involved in the regulation of energy homeostasis. Phase 2.TargetsSIRT1In vitroSRT2104 reduces p65/RelA acetylation levels in C2C12 cells.In vivoIn male C57BL/6J mice, SRT2104 (100 mg/kg, p.o.) extends both mean and maximal lifespan of mice fed a standard diet, and enhances motor coordination, bone mineral density, and insulin sensitivity and decreased inflammation. Short-term SRT2104 treatment preserves bone and muscle mass in an experimental model of atrophy. In Male N171-82Q HD mice, SRT2104 (diet containing 0.5% SRT2104) effectively penetrates the blood-brain barrier, attenuates brain atrophy, improves motor function, and extends survival.Cell Research(from reference)Cell lines:C2C12 cell line Concentrations:3\xa0μM Incubation Time:24 h |
| 体内研究: |
SRT 2104 (100mg/kg/天,在饮食中添加,持续 24 周) 可增加糖尿病小鼠的 SIRT1 蛋白水平,但不改变 Sirt1 mRNA 水平。 SRT 2104 (100mg/kg/天,在饮食中添加,持续 24 周) 可降低糖尿病小鼠睾丸的氧化应激、细胞凋亡信号激活和内质网应激。 SRT 2104 (0.5%;持续 18 周) 可改善 N171-82Q 亨廷顿舞蹈病 (HD) 小鼠的运动功能并延长生存期。 |
| 参考文献: |
1. Hoffmann E, et al. Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man. 2. Jiao D, et al. MicroRNA-34a targets sirtuin 1 and leads to diabetes-induced testicular apoptotic cell death. J Mol Med (Berl). 2018 Sep;96(9):939-949. 3. Jiang M, et al. Sirtuin 1 activator SRT2104 protects Huntington's disease mice. Ann Clin Transl Neurol. 2014 Dec;1(12):1047-52. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.936 ml |
9.678 ml |
19.356 ml |
| 5 mM |
0.387 ml |
1.936 ml |
3.871 ml |
| 10 mM |
0.194 ml |
0.968 ml |
1.936 ml |
| 50 mM |
0.039 ml |
0.194 ml |
0.387 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |